PD Neurotechnology


April 8, 2019

Parkinson’s Disease (PD) is affecting close to 12 million people worldwide. The severity of the disease and the impact on a patient’s life highly depend on the optimal timing and dosing of the prescribed therapy, which affects the symptoms, the quality of life, the disease progression and the life longevity of the patient.